LV9 Stock Overview
Lotus Ventures Inc. engages in the production, cultivation, and sale of cannabis products for medical purpose in Canada.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Lotus Ventures Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.0005 |
52 Week High | CA$0.028 |
52 Week Low | CA$0.0005 |
Beta | -0.30 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | -97.14% |
3 Year Change | -99.52% |
5 Year Change | -99.71% |
Change since IPO | -99.77% |
Recent News & Updates
Recent updates
Shareholder Returns
LV9 | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 0% | 2.1% | 1.6% |
1Y | -97.1% | -26.3% | 6.4% |
Return vs Industry: LV9 underperformed the German Pharmaceuticals industry which returned -25.6% over the past year.
Return vs Market: LV9 underperformed the German Market which returned 6.4% over the past year.
Price Volatility
LV9 volatility | |
---|---|
LV9 Average Weekly Movement | 212.4% |
Pharmaceuticals Industry Average Movement | 6.3% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LV9's share price has been volatile over the past 3 months.
Volatility Over Time: LV9's weekly volatility has increased from 122% to 212% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Dale McClanaghan | https://www.lotuscannabis.ca |
Lotus Ventures Inc. engages in the production, cultivation, and sale of cannabis products for medical purpose in Canada. It owns Lotus Cannabis Co., a premium-craft consumer brand and sells its Keylime Kush flower and prerolls in British Columbia. The company is based in Vancouver, Canada.
Lotus Ventures Inc. Fundamentals Summary
LV9 fundamental statistics | |
---|---|
Market cap | €781.76k |
Earnings (TTM) | -€1.27m |
Revenue (TTM) | €1.36m |
0.9x
P/S Ratio-0.9x
P/E RatioIs LV9 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LV9 income statement (TTM) | |
---|---|
Revenue | CA$2.00m |
Cost of Revenue | CA$2.14m |
Gross Profit | -CA$137.15k |
Other Expenses | CA$1.74m |
Earnings | -CA$1.87m |
Last Reported Earnings
Aug 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.016 |
Gross Margin | -6.86% |
Net Profit Margin | -93.71% |
Debt/Equity Ratio | 26.7% |
How did LV9 perform over the long term?
See historical performance and comparison